Clinical Trials on Impaired Glucose Tolerance in South Africa
Total 899 results
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Taiwan, Australia, Hungary, Germany, India, Canada, Spain, Czechia, Argentina, Poland, Colombia, South Africa, France, Greece, Romania
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Type 2 DiabetesUnited States
-
PhenomixUnknownType 2 Diabetes MellitusUnited States, Argentina, Canada, India, Mexico
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteRecruitingType2Diabetes | ASCVDUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Sweden, United States, Mexico, South Africa, Russian Federation, France, Spain, Switzerland, Canada, Finland, New Zealand, Korea, Republic of, Thailand, Israel, Germany, Peru, Australia, Denmark, Italy, Ukraine, Greece, Puerto Rico, Guatemal... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, United Kingdom, Denmark, France, Austria, Czech Republic, Australia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Finland, Israel, Japan, New Zealand, Slovakia, Sweden
-
TakedaTakeda Development Center Americas, Inc.CompletedDiabetes Mellitus, Type 2United States, Italy, Mexico, Russian Federation, Brazil, Israel, Poland
-
TakedaCompletedDiabetes MellitusUnited States, Ukraine, Romania, Chile, Russian Federation, Czech Republic, Lithuania, Slovakia, Latvia, Hungary, Guatemala, Puerto Rico
-
TakedaEli Lilly and CompanyCompletedDiabetes MellitusUnited States
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Russian Federation, Slovakia, Spain, Canada, Taiwan, Finland, Hungary, Malaysia, South Africa, United Kingdom, Germany, Australia, Thailand, Ireland, Puerto Rico, Singapore
-
Mellitus, LLCRegulatory and Clinical Research Institute IncWithdrawnGestational DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Hungary, India, Japan, Poland, Russian Federation
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Russian Federation, United Kingdom, South Africa
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Poland, Ukraine, United Kingdom, Mexico, Spain, Romania, Israel, Canada, New Zealand, Singapore, Russian Federation, Chile, Puerto Rico, Thailand, Hungary, Austria, Lithuania, Malaysia, Philippines, Australia, India, South... and more
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Malaysia, Germany, Algeria, Turkey
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Mexico
-
AstraZenecaCompletedType 2 Diabetes MellitusCanada, United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Macedonia, The Former Yugoslav Republic of, Russian Federation, Turkey, Croatia, Australia, Philippines
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes | HyperlipidemiaUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Israel, Russian Federation, United Kingdom, Canada, Belgium, Germany, Australia
-
Novo Nordisk A/SCompletedObesityUnited Kingdom, Canada, Denmark, Finland, Spain
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2India, Turkey, United States, Puerto Rico, Taiwan, Korea, Republic of, Russian Federation
-
Mylan Inc.Mylan GmbHCompletedType 1 DiabetesUnited States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
National Institute of Diabetes and Digestive and...Recruiting
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Germany, Hungary
-
ConjuChemTerminatedType 2 Diabetes Mellitus (T2DM)United States, Canada
-
PfizerCompletedDiabetes MellitusUnited States, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
-
InVasc Therapeutics, Inc.CompletedHypertension | Diabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Italy, Russian Federation, United Kingdom, Denmark, Austria, Serbia, Canada, Croatia, Australia, Greece, Ireland, Brazil, Spain, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, India, Taiwan, Poland, Australia, Estonia, Hungary, Germany, Slovakia, Canada, Croatia, Bulgaria, Puerto Rico, Czechia, Slovenia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyUnited States, Canada, France, Hong Kong, India, Malaysia, Netherlands, Philippines, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation